Bingo! [Two-Stage / GS Designs]

posted by jatkins_5 – Philippines, 2014-10-30 04:53 (3837 d 06:39 ago) – Posting: # 13814
Views: 8,739

An option would be to use EMA’s approach of “leaving one out”; you would get only the pooled variance of the remaining pair.


Good day sirs!

In the above quote, is it statistically valid to establish ANOVA using drugs A and B only (as if done like a 2-way 2-seq crossover) in stage 1 (Potvin Method C) even though the study was done on a 3-way 6-seq crossover (Williams design) with drugs A, B and C? (asssuming the protocol specifically states that sequential BE shall be done on drugs A and B only; drug C shall be done for descriptive statistics determination only). Also, may I ask what specific EMA guideline mentioned the above approach so I could explore the topic further. I know a lot of discussion has already been poured on sequential BE, but I couldn't find a specific answer to my query. Many thanks in advance!

jerry

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
63 visitors (0 registered, 63 guests [including 7 identified bots]).
Forum time: 12:33 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5